Edwards Lifesciences Corporation

BOVESPA:E1WL34 Stock Report

Market Cap: R$241.3b

Edwards Lifesciences Future Growth

Future criteria checks 0/6

Edwards Lifesciences is forecast to grow earnings and revenue by 2.6% and 4.8% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 15.8% in 3 years.

Key information

2.6%

Earnings growth rate

1.8%

EPS growth rate

Medical Equipment earnings growth18.2%
Revenue growth rate4.8%
Future return on equity15.8%
Analyst coverage

Good

Last updated15 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:E1WL34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,5691,6651,5841,87521
12/31/20255,9871,5471,5991,87925
12/31/20245,9251,3891,7672,07311
6/30/20246,2041,540552866N/A
3/31/20246,1141,428251528N/A
12/31/20236,0051,402630896N/A
9/30/20235,3621,3417751,042N/A
6/30/20235,2011,300669940N/A
3/31/20235,2791,4519721,239N/A
12/31/20225,3821,5229531,218N/A
9/30/20225,3641,4591,0401,309N/A
6/30/20225,3551,4551,2611,531N/A
3/31/20225,3571,5391,4281,725N/A
12/31/20215,2331,5031,4021,732N/A
9/30/20215,0951,4771,4091,758N/A
6/30/20214,9251,4621,0501,443N/A
3/31/20214,4748517171,148N/A
12/31/20204,3868236471,054N/A
9/30/20204,3697946921,057N/A
6/30/20204,3227449411,279N/A
3/31/20204,4841,1081,0871,389N/A
12/31/20194,3481,0479051,183N/A
9/30/20194,1527748091,073N/A
6/30/20193,964725705978N/A
3/31/20193,821765523777N/A
12/31/20183,723722685927N/A
9/30/20183,634712754998N/A
6/30/20183,549657772966N/A
3/31/20183,447560N/A1,024N/A
12/31/20173,435584N/A1,001N/A
9/30/20173,315745N/A838N/A
6/30/20173,232716N/A733N/A
3/31/20173,150657N/A726N/A
12/31/20162,964570N/A704N/A
9/30/20162,867552N/A607N/A
6/30/20162,743528N/A604N/A
3/31/20162,601515N/A584N/A
12/31/20152,494495N/A550N/A
9/30/20152,441463N/A539N/A
6/30/20152,433440N/A349N/A
3/31/20152,391874N/A957N/A
12/31/20142,323811N/A1,022N/A
9/30/20142,241777N/A1,040N/A
6/30/20142,129759N/A1,160N/A
3/31/20142,071306N/A511N/A
12/31/20132,046389N/A473N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: E1WL34's forecast earnings growth (2.6% per year) is below the savings rate (10.1%).

Earnings vs Market: E1WL34's earnings (2.6% per year) are forecast to grow slower than the BR market (14% per year).

High Growth Earnings: E1WL34's earnings are forecast to grow, but not significantly.

Revenue vs Market: E1WL34's revenue (4.8% per year) is forecast to grow slower than the BR market (7.6% per year).

High Growth Revenue: E1WL34's revenue (4.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: E1WL34's Return on Equity is forecast to be low in 3 years time (15.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y